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Abstract Rainbow trout were used as a model system to
evaluate the role of glucose in regulating the expression of
preprosomatostatin I. Glucose increased pancreatic levels of
preprosomatostatin I mRNA in vivo, in concert with elevated
plasma somatostatin levels, and in vitro. Glucose-stimulated
expression of preprosomatostatin I mRNA required the uptake,
phosphorylation, and subsequent metabolism of the sugar in
pancreatic islets. These results suggest that glucose modulates
both the production and release of somatostatin.
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1. Introduction
The somatostatin (SS) family of peptide hormones has been
shown to regulate various aspects of growth, development,
and metabolism in vertebrates [1]. Peptides ranging in length
from 14 to 37 amino acids and/or varying in amino acid
composition, depending on species, have been isolated from
numerous tissues, including the central and peripheral nervous
systems, the gastrointestinal tract, pancreatic islets, and thy-
roid tissue [2,3]. The molecular heterogeneity of the SS family
stems from tissue-speci¢c variations in biosynthesis from a
single larger precursor molecule as well as from the existence
of multiple precursors presumably derived from di¡erent
genes. The di¡erent forms of SS observed in mammals (e.g.
SS-28) are N-terminal extensions of SS-14, the ¢rst somato-
statin described, and result from di¡erential processing of the
same precursor, preprosomatostatin (PPSS) I [4]. Lampreys,
numerous teleost ¢shes, and frogs possess PPSSs in addition
to PPSS I; in the case of teleosts and frogs, the PPSSs derive
from di¡erent mRNAs [3,5,6].
Relatively little is known about the control of SS biosyn-
thesis and secretion. In mammals, studies have been hampered
by the relatively low number of SS-secreting cells in their
islets. However, food deprivation as well as in vivo glucose
administration were shown to elevate plasma SS-14 levels in
mammals [7]. Studies on teleost ¢shes, which have proved to
be particularly good models for the study of SS because they
possess a large principal islet (Brockmann body) that is easily
separated from exocrine tissue and because this islet possesses
a relatively high amount of SS compared to mammalian islets
[8], have provided important insight into nutritional regula-
tion of SS secretion. Food deprivation as well as in vivo and
in vitro glucose administration have been shown to stimulate
the release of SS-14 [9^13]. At present, however, no informa-
tion exists on the e¡ects of nutrients on SS gene expression or
on SS biosynthesis.
In this study, rainbow trout were used as a model system to
evaluate the control of SS gene expression. We examined for
the ¢rst time the e¡ects of glucose on the expression of PPSS I
mRNA. The mechanisms by which glucose a¡ects the expres-
sion of PPSS I mRNA also were examined. The results of this
study contribute to the overall understanding of how the pro-
duction and secretion of SS is controlled.
2. Materials and methods
2.1. Animals
Juvenile rainbow trout (Oncorhynchus mykiss) of both sexes were
obtained from Dakota Trout Ranch near Carrington, ND, and trans-
ported to North Dakota State University where they were maintained
in 800-l circular tanks supplied with recirculated (10% make-up vol-
ume per day) dechlorinated municipal water at 14‡C under a 12:12 h
light^dark photoperiod. Fish were fed to satiety twice daily with
Supersweet Feeds (Glenco, MN, USA) trout grower, except 24^36 h
before in vivo or in vitro experiments. Animals were acclimated to
laboratory conditions for at least 4 weeks prior to experiments.
For in vivo experiments, animals were transferred to 50-l aquaria
(10 ¢sh/aquarium; one aquarium for each of the following treat-
ments: 3 h saline, 3 h glucose, 12 h saline, and 12 h glucose) and
their feeding was suspended. Thirty-six hours later, the ¢sh were anes-
thetized with 0.05% (v/v) 2-phenoxyethanol (Sigma), weighed, injected
(10 Wl/g body weight) with either 0.75% (w/v) NaCl (control) or 3000
mg/dl glucose (treated) as described previously [10], and then replaced
into their aquarium. At various times after injection, the animals were
re-anesthetized and blood and Brockmann bodies were removed. Se-
rum and tissues were immediately frozen on dry ice and stored at
390‡C until further analysis, usually within 2 weeks. Hematocrits
between the saline- and glucose-injected animals did not di¡er signi¢-
cantly.
For in vitro experiments, the ¢sh were anesthetized and their Brock-
mann bodies removed and prepared for culture as described previ-
ously [12]. Isolated hemi-islets were placed in 24-well culture plates
(ca. 2^3 hemi-islets per well) and preincubated (14‡C, 100% O2, shak-
en at 120 rpm with a gyratory shaker) for 2 h in 1 ml of basal medium
(in mM: 137 NaCl, 5.4 KCl, 4 NaHCO3, 1.7 CaCl2, 0.8 MgSO4, 0.5
KH2PO4, 0.3 Na2HPO4, 10 HEPES, 0.24% bovine serum albumin).
Following preincubation, the medium was removed, the islets were
washed gently with 1 ml of fresh basal medium, and 1 ml of test
medium was added to each well. Test solutions were prepared by
adjusting the NaCl concentration so that all solutions were isoos-
motic. All of the test agents, including hexoses, analogs and inhibi-
tors, were obtained from Sigma (St. Louis, MO). Incubation pro-
ceeded under the same conditions as preincubation for up to 24 h,
after which the medium was removed and the islets were immediately
frozen on dry ice. Islets were stored at 390‡C until RNA extraction
and quantitation.
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2.2. mRNA quantitation and plasma hormone and metabolite analyses
Total RNA was extracted from Brockmann bodies using the TRI
Reagent0 protocol (Molecular Research Center, Inc., Cincinnati,
OH). PPSS I mRNA was measured using a quantitative slot-blot
technique [6] in which in vitro synthesized cRNA standards were
blotted onto a nylon membrane along with sample RNA (Fig.
1B,C). The membranes were ¢rst hybridized with a gene-speci¢c
32P-labeled oligonucleotide probe and quanti¢ed with the Packard
Cyclone Imaging System (Meriden, CT). This probe was highly spe-
ci¢c and did not cross-hybridize with other mRNA species (Fig. 1A).
Sample blots were then stripped and rehybridized with a full-length
32P-labeled Q-actin probe and requanti¢ed. Following correction for
background and normalization to Q-actin, mRNA levels were ex-
pressed as molecules of mRNAU108 per Wg total RNA (Fig. 1).
Plasma concentrations of glucose [14] and SS-14 [12] were measured
as previously described.
2.3. Statistics
Statistical di¡erences were estimated by analysis of variance; multi-
ple comparisons among means were made with the Student^Newman^
Keuls test. Di¡erences were considered signi¢cant at P6 0.05. For
ease of comparison, data were expressed as % change from control;
statistics were performed on untransformed data.
3. Results
3.1. In vivo experiment
The e¡ects of glucose on pancreatic expression of PPSS I
mRNA were ¢rst studied in vivo. Injection of ¢sh with glu-
cose (3000 mg/dl) resulted in hyperglycemia that lasted for up
to 12 h (Fig. 2A), a pattern that was similar to our previous
observations [10]. The hyperglycemia was attended by ele-
vated plasma concentrations of SS-14 (Fig. 2B). Alterations
in plasma levels of SS-14 corresponded to changes in the
steady-state levels of PPSS I mRNA in the Brockmann bodies
of trout injected with glucose (Fig. 2C). Whether or not the
e¡ects of glucose on the expression of PPSS I mRNA resulted
from a direct action was evaluated by in vitro incubation of
Brockmann bodies.
3.2. In vitro experiments
Glucose directly stimulated the expression of PPSS I
mRNA in Brockmann bodies incubated in vitro. Steady-state
levels of PPSS I mRNA increased in a dose-dependent man-
ner (Fig. 3A); the maximum response to glucose was at a
concentration of 10 mM. Steady-state levels of PPSS I
mRNA rose quickly in response to 10 mM glucose, reaching
maximum expression after 6 h; thereafter, RNA levels de-
clined (Fig. 3B). All of the hexoses tested (mannose, galactose,
fructose, glucose) induced the expression of PPSS I mRNA;
the e¡ects of fructose and galactose were particularly pro-
nounced (Fig. 3C).
The mechanisms by which glucose stimulates the expression
of PPSS I mRNA were studied in several experiments. Su-
crose, a disaccharide which does not enter cells readily, had
no e¡ect on the expression of PPSS I mRNA (Fig. 4A). In
addition, neither 3-o-methyl glucose, a compound that enters
cells but does not get phosphorylated, nor 2-deoxyglucose, a
compound which enters cells and gets phosphorylated but not
metabolized further, altered the steady-state levels of PPSS I
mRNA (Fig. 4A). On the other hand, metabolites such as
glycerol, dihydroxyacetone, pyruvate, and lactate, signi¢cantly
stimulated the levels of PPSS I mRNA (Fig. 4B). An inhibitor
of glycolysis, iodoacetate, signi¢cantly reduced the levels of
Fig. 1. Quantitative slot-blot analysis of PPSS I mRNA. Serial dilu-
tions of in vitro synthesized cRNA standards (B) and samples were
subjected to slot-blot analysis using a 32P-labelled oligonucleotide
probe. Northern analysis (A) indicated that this probe was speci¢c
for the 745-nt PPSS I transcript. Autoradiograms of blots were
quantitated using phosphor imaging and, after correction for back-
ground, were plotted (C) as a function of number of molecules/Wg
total RNA.
Fig. 2. E¡ects of glucose injection (3000 mg/dl at 10 Wl/g body
weight) on the plasma concentration of glucose (A), somatostatin
(B), and on the expression of pancreatic PPSS I mRNA (C). Data
are presented as % change from saline-injected control (mean þ
S.E.M.; n = 10) and representative slot blots (inset). Control values
at 3 h and 12 h, respectively, for glucose were 111.7 þ 7.2 mg/100
ml and 104.8 þ 6.8 mg/100 ml and for somatostatin were 0.41 þ 0.02
ng/ml and 0.44 þ 0.03 ng/ml. Groups with di¡erent letters are signi¢-
cantly (P6 0.05) di¡erent from one another; *signi¢cantly di¡erent
from control.
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PPSS I mRNA (Fig. 4B). Dichloroacetate, which increases
£ux into the Krebs cycle, as well as intermediates of the Krebs
cycle, such as acetate and citrate, also enhanced the levels of
PPSS I mRNA (Fig. 4C).
4. Discussion
The results of this study indicate that glucose modulates the
expression of the PPSS I mRNA. The e¡ects of glucose are
direct and rapid. These ¢ndings, the ¢rst reporting the e¡ects
of metabolites on the levels of PPSS mRNAs, suggest that
glucose stimulates the biosynthesis as well as the secretion
of somatostatins, peptides important in the regulation of
growth, development, and metabolism of vertebrates [1].
Glucose-stimulated expression of PPSS I mRNA requires
cellular entry and the subsequent metabolism of the sugar.
This conclusion is supported by several observations. First,
sucrose, a disaccharide which does not enter cells readily,
had no e¡ect on PPSS I expression; this lack of an e¡ect
also excludes the possibility of an osmotic action. Second, a
variety of hexoses, including glucose, galactose, and fructose,
which enter cells and undergo phosphorylation, isomerization
and metabolism to varying degrees, all stimulated PPSS I
mRNA expression. Third, that hexose-stimulated PPSS I
mRNA expression requires phosphorylation was supported
by the failure of the glucose analog, 3-o-methyl glucose, to
alter steady-state levels of PPSS I mRNA. Phosphorylation
alone, however, does not appear to be su⁄cient for hexose-
stimulated PPSS I mRNA expression. This is indicated by the
inability of the glucose analog, 2-deoxyglucose, to a¡ect PPSS
I mRNA expression. Lastly, the requirement for the subse-
quent metabolism of glucose through glycolysis and Krebs
cycle was indicated by the ability of metabolites such as dihy-
droxyacetone, glycerol, lactate, pyruvate, acetate, and citrate
to stimulate the levels of PPSS I mRNA. Inhibition of glycol-
ysis with iodoacetate signi¢cantly reduced the levels of PPSS I
mRNA. Moreover, increased £ux through the Krebs cycle, via
dichloroacetate action on mitochondrial pyruvate dehydro-
genase activity, stimulated the levels of PPSS I mRNA. To-
gether, the present ¢ndings suggest that the proximate medi-
ator of glucose-stimulated PPSS I expression is generated after
the aldolase step of glycolysis.
Fig. 3. E¡ects of glucose (A, B) and of other hexoses (C) on the ex-
pression of PPSS I mRNA in rainbow trout Brockmann bodies in-
cubated in vitro. Tissues were incubated for 6 h with the concentra-
tion of hexose indicated (A, C) or for various times with 10 mM
glucose (B). Data are presented as representative slot blots (insets)
and as % change (mean þ S.E.M.; n = 6) from 1 mM glucose (A);
time 0 h (B); 4 mM glucose control (C). Groups with di¡erent let-
ters are signi¢cantly (P6 0.05) di¡erent from one another; *signi¢-
cantly di¡erent from control.
Fig. 4. E¡ects of sucrose and various glucose analogs (A) and of se-
lected intermediates, inhibitors, or stimulators of glycolysis (B) and
the Krebs cycle (C) on the expression of PPSS I mRNA in rainbow
trout Brockmann bodies incubated in vitro for 6 h. Data are pre-
sented as representative slot blots (insets) and as % change (mean þ
S.E.M.; n = 6) from control (4 mM glucose). Groups with di¡erent
letters are signi¢cantly (P6 0.05) di¡erent from one another for a
given mRNA species; *signi¢cantly di¡erent from control.
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The exact mechanism(s) by which glucose stimulates steady
state levels of PPSS I mRNA is (are) not known. Whether the
proximate mediators produced during the metabolism of glu-
cose activate speci¢c trans-acting factors that, in turn, modu-
late gene expression via carbohydrate-responsive elements in
promoter regions of the SS gene is a possibility that requires
further study. It also should be noted that an in£uence of
glucose metabolism on the stability of PPSS I mRNA cannot
be ruled out.
The ¢nding that glucose stimulates the expression of PPSS I
mRNA extends our knowledge of the e¡ects of glucose on SS
production. Previously, glucose administration in vivo has
been shown to elevate plasma somatostatin levels in ¢sh [10]
and mammals [7]. In addition, glucose stimulated the secre-
tion of SS-14, a principal SS form located at the C-terminus
of PPSS I, directly from pancreatic preparations of numerous
species of ¢sh [9,11,12,15] and mammals [16]. The present
¢ndings indicate that glucose-stimulated release of SS-14,
both in vivo and in vitro, results, at least in part, from the
increased expression of PPSS I mRNA. The regulation of SS
biosynthesis and secretion by glucose has important implica-
tions for the nutritional and metabolic physiology of verte-
brate organisms. Glucose-modulated SS production provides
an important feedback control on the release of other meta-
bolically important hormones such as insulin and glucagon in
so far as SSs have been shown to inhibit the release of these
factors both in ¢sh [17] and in mammals [2].
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